Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200433, China
NCT Number: NCT07036419
The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.
Looking for future studies?
Notify Me3 year–17 year
All sexes
Interventional
Phase 2 / Phase 3
Shanghai, Shanghai Municipality, 200433, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Remimazolam Tosilate for injection.
Propofol injection.
Time frame: Throughout the anesthesia procedure.
The overall sedation success rate, which encompasses both successful induction of sedation and successful maintenance of adequate sedation throughout the anesthesia procedure.
Time frame: Up to 2 days.
Defined as a ≥ ±20% change from the baseline in blood pressure or heart rate.
Time frame: Up to 3 days.
Jiangsu HengRui Medicine Co., Ltd.
Industry
A Clinical Study on Efficacy and Safety of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.